These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37247084)

  • 21. Identification of novel bacteriophage vB_EcoP-EG1 with lytic activity against planktonic and biofilm forms of uropathogenic Escherichia coli.
    Gu Y; Xu Y; Xu J; Yu X; Huang X; Liu G; Liu X
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):315-326. PubMed ID: 30397766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
    Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients.
    Malekzadegan Y; Khashei R; Sedigh Ebrahim-Saraie H; Jahanabadi Z
    BMC Infect Dis; 2018 Nov; 18(1):572. PubMed ID: 30442101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and characterization of class 1 integrons in Escherichia coli from healthy individuals and those with urinary infection.
    Oliveira-Pinto C; Diamantino C; Oliveira PL; Reis MP; Costa PS; Paiva MC; Nardi RMD; Magalhães PP; Chartone-Souza E; Nascimento AMA
    J Med Microbiol; 2017 May; 66(5):577-583. PubMed ID: 28485709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulence properties of uropathogenic Escherichia coli isolated from children with urinary tract infection in Korea.
    Kim DH; Subhadra B; Kang HY; Woo K; Kim J; Son YJ; Sohn KM; Kim HJ; Han K; Oh MH; Choi CH
    Genes Genomics; 2018 Jun; 40(6):625-634. PubMed ID: 29892947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Emerging Lineage of Uropathogenic Extended Spectrum β-Lactamase Escherichia coli ST127.
    Cave R; Ter-Stepanyan MM; Kotsinyan N; Mkrtchyan HV
    Microbiol Spectr; 2022 Dec; 10(6):e0251122. PubMed ID: 36416548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates.
    Yazdanpour Z; Tadjrobehkar O; Shahkhah M
    BMC Microbiol; 2020 Aug; 20(1):241. PubMed ID: 32758126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance and molecular epidemiology of carbapenem-resistant Escherichia coli from urinary tract infections in Shandong, China.
    Chen R; Wang G; Wang Q; Zhang M; Wang Y; Wan Z; Si Z; Bai Y; Song Z; Lu X; Hao Y
    Int Microbiol; 2023 Nov; 26(4):1157-1166. PubMed ID: 37145384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
    de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM
    Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Snapshot of Phylogenetic Groups, Virulence, and Resistance Markers in
    Cristea VC; Gheorghe I; Czobor Barbu I; Popa LI; Ispas B; Grigore GA; Bucatariu I; Popa GL; Angelescu MC; Velican A; Marutescu L; Popa M; Chifiriuc MC; Popa IM
    Biomed Res Int; 2019; 2019():5712371. PubMed ID: 31236408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
    Rezatofighi SE; Mirzarazi M; Salehi M
    BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia.
    Abd El Ghany M; Sharaf H; Al-Agamy MH; Shibl A; Hill-Cawthorne GA; Hong PY
    PLoS One; 2018; 13(8):e0201613. PubMed ID: 30110357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance, virulence factors and genotyping of Uropathogenic
    Raeispour M; Ranjbar R
    Antimicrob Resist Infect Control; 2018; 7():118. PubMed ID: 30305891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uropathogenic Escherichia coli strains harboring tosA gene were associated to high virulence genes and a multidrug-resistant profile.
    Xicohtencatl-Cortes J; Cruz-Córdova A; Cázares-Domínguez V; Escalona-Venegas G; Zavala-Vega S; Arellano-Galindo J; Romo-Castillo M; Hernández-Castro R; Ochoa SA; Luna-Pineda VM
    Microb Pathog; 2019 Sep; 134():103593. PubMed ID: 31195111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic Resistance Among Uropathogenic
    Kot B
    Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidoglycan Sensing Prevents Quiescence and Promotes Quorum-Independent Colony Growth of Uropathogenic Escherichia coli.
    DiBiasio EC; Ranson HJ; Johnson JR; Rowley DC; Cohen PS; Camberg JL
    J Bacteriol; 2020 Sep; 202(20):. PubMed ID: 32778561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.
    Toval F; Köhler CD; Vogel U; Wagenlehner F; Mellmann A; Fruth A; Schmidt MA; Karch H; Bielaszewska M; Dobrindt U
    J Clin Microbiol; 2014 Feb; 52(2):407-18. PubMed ID: 24478469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.